Diagnosing and treating psoriatic arthritis: an update
- 23 November 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 170 (4), 772-786
- https://doi.org/10.1111/bjd.12748
Abstract
Psoriatic arthritis (PsA) is an inflammatory arthritis of uncertain pathogenesis, affecting approximately one in four patients with psoriasis. Onset of psoriasis typically precedes the development of PsA. Therefore, the dermatologist is ideally positioned to recognize the early signs and symptoms of PsA for diagnosis and subsequent treatment. The role of the dermatologist in early diagnosis and treatment is essential for preventing pain and functional disabilities, as well as the joint deterioration that accompanies progressive forms of PsA. Diagnosis of PsA is a key aspect of the clinical decision process for the dermatologist, as psoriasis plus PsA requires a different therapeutic approach from that required for psoriasis alone. Furthermore, PsA is associated with an increased risk of cardiovascular comorbidities that present significant health concerns. In this review, the pathogenesis and comorbidities of PsA are discussed. In addition, screening and imaging tools that aid in the diagnosis of PsA, as well as tools used for efficacy assessment, are reviewed. Available therapies are presented, with a focus on targeted biologics and emerging treatments.This publication has 100 references indexed in Scilit:
- Effect of 1-year anti-TNF-α therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled studyAmerican Journal of Hypertension, 2012
- Systematic Review and Meta-Analysis of Methotrexate Use and Risk of Cardiovascular DiseaseThe American Journal of Cardiology, 2011
- Inflammatory bowel disease associated arthropathyCurrent Reviews in Musculoskeletal Medicine, 2011
- Increased Prevalence of the Metabolic Syndrome in Patients with Psoriatic ArthritisMetabolic Syndrome and Related Disorders, 2010
- A sonographic spectrum of psoriatic arthritis: “the five targets”Clinical Rheumatology, 2009
- Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaireArchiv für dermatologische Forschung, 2009
- Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population‐based studyArthritis Care & Research, 2009
- Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritisArthritis & Rheumatism, 1995
- The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trialsArthritis & Rheumatism, 1993
- Measurement of patient outcome in arthritisArthritis & Rheumatism, 1980